The Emerging Cloud: a survey of vapers, their health and utilization of healthcare within the UK
Abstract Background: Recent work in the UK estimated the prevalence of current cannabinoid-based vaping to be higher than in the USA, a factor previously associated with e-cigarette or vaping-associated lung injury (EVALI). Research in the USA has demonstrated that attendances to emergency departments relating to e-cigarettes began to rise before the EVALI outbreak, suggesting that vapers also experience milder forms of vaping-related illness. Aim: Quantify symptom prevalence and healthcare utilization amongst current UK vapers. Design: Voluntary online survey of individuals
This article is available to registered members
Create a free account to access our full library of peer-reviewed research on medical cannabis.
Join — it's freeAlready a member? Log in
